MK-677 (Ibutamoren) is a non-peptide compound that mimics the activity of ghrelin, a hormone involved in growth hormone (GH) regulation
ADHD with comorbidities (F90.x): ADHD alone does not consistently trigger HHS-HCC assignment
This information should be interpreted alongside your clinical history, laboratory results, and provider assessment
Use this as a reference point, then read the deeper sections below for the full picture
Expected Timeline Weeks 14: Appetite change Weeks 48: Visible weight change Weeks 812: Metabolism becomes more efficient 12+ weeks: Steady monthly results Who Should Avoid GLP-1 (Rare Cases) History of Medullary Thyroid Cancer Family history of MEN2 Uncontrolled hypothyroidism (TSH extremely high) Severe GI disorders (gastroparesis, bowel obstruction) I will not start GLP-1 if your bloodwork is unstable or you show severe symptoms like: Persistent fast heart rate Severe constipation Unmanaged fatigue Gastrointestinal blockage history What to Expect If You Start GLP-1 With Hypothyroidism Heres the exact guidance I give patients: Dose Titration Start low
Protocols, doses, and reactions reported below come from published clinical trials and self-reported community sources